| |
| |
|
| Insider
Information: |
Lenz Brian |
| Relationship: |
|
| City: |
Monmouth Junction |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
739,002 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,694,978 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
739,002 |
|
|
| Total
Value |
$4,694,978 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
2
|
|
Stock
price went up :
|
2
|
2
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
 -1.1%
|
 86.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vioquest Pharmaceuticals |
VOQP |
CFO and Treasurer |
2008-01-14 |
15,000 |
2005-12-09 |
0 |
Premium* |
|
|
Arno therapeutics Inc |
ARNI |
Chief Financial Officer |
2008-09-08 |
4,000 |
2008-09-08 |
0 |
Premium* |
|
|
Cormedix Inc. |
CRMD |
CFO, TREASURER & SECRE... |
2011-12-14 |
17,000 |
2010-03-30 |
0 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
|
2024-03-07 |
703,002 |
2013-10-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2024-03-07 |
4 |
D |
$6.16 |
$104,504 |
D/D |
(16,965) |
703,002 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2024-03-06 |
4 |
D |
$6.12 |
$102,063 |
D/D |
(16,677) |
719,967 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2024-02-29 |
4 |
D |
$5.36 |
$26,452 |
D/D |
(4,935) |
736,644 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2024-02-25 |
4 |
D |
$5.26 |
$43,432 |
D/D |
(8,257) |
741,579 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-12-31 |
4 |
D |
$4.52 |
$76,424 |
D/D |
(16,908) |
749,836 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-09-30 |
4 |
D |
$3.58 |
$54,659 |
D/D |
(15,268) |
766,744 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-08-16 |
4 |
S |
$4.45 |
$793,400 |
D/D |
(178,184) |
782,013 |
0 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-08-15 |
4 |
D |
$4.61 |
$2,909,270 |
D/D |
(631,078) |
960,197 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-08-15 |
4 |
OE |
$1.67 |
$2,514,363 |
D/D |
809,262 |
1,591,275 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-08-15 |
4 |
S |
$4.60 |
$972,730 |
D/D |
(211,578) |
782,013 |
0 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-06-30 |
4 |
D |
$3.69 |
$56,339 |
D/D |
(15,268) |
993,591 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-03-07 |
4 |
D |
$3.40 |
$57,681 |
D/D |
(16,965) |
1,024,327 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
135,175 |
1,041,292 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-02-28 |
4 |
D |
$3.55 |
$17,750 |
D/D |
(5,000) |
906,117 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2023-02-25 |
4 |
D |
$3.42 |
$32,442 |
D/D |
(9,486) |
911,117 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2022-12-09 |
4 |
B |
$2.86 |
$20,000 |
D/D |
6,993 |
1,034,825 |
0.01 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2022-09-30 |
4 |
D |
$2.43 |
$179,038 |
D/D |
(73,678) |
1,027,832 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2022-05-11 |
4 |
D |
$1.43 |
$74,310 |
D/D |
(51,965) |
1,101,510 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2022-03-23 |
4 |
D |
$1.46 |
$54,280 |
D/D |
(37,178) |
1,153,475 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
137,500 |
1,190,653 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$30,000 |
D/D |
30,000 |
1,065,501 |
0.01 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
900,000 |
1,035,501 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
63,936 |
140,078 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2020-08-11 |
4 |
B |
$2.97 |
$11,860 |
D/D |
4,000 |
76,142 |
2.74 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
72,142 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
